By , CHENNAI/NEW DELHI (Reuters) - India’s drugs regulator on Saturday recommended for emergency use a locally developed coronavirus vaccine called COVAXIN, which is expected to be a backup to the AstraZeneca/Oxford shot.COVAXIN has been developed by Bharat Biotech, a company bas...